BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 9754852)

  • 1. Hepatitis caused by antidepressive therapy with maprotiline and opipramol.
    Braun JS; Geiger R; Wehner H; Schäffer S; Berger M
    Pharmacopsychiatry; 1998 Jul; 31(4):152-5. PubMed ID: 9754852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modern indications for the use of opipramol.
    Krysta K; Murawiec S; Warchala A; Zawada K; Cubała WJ; Wiglusz MS; Jakuszkowiak-Wojten K; Krzystanek M; Krupka-Matuszczyk I
    Psychiatr Danub; 2015 Sep; 27 Suppl 1():S435-7. PubMed ID: 26417811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Case report of hepatotoxicity associated with maprotiline.
    Weinstein RP; Gosselin JY
    Can J Psychiatry; 1988 Apr; 33(3):233-4. PubMed ID: 3383098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A case of allergic cross reaction between tricyclic antidepressants and maprotiline].
    Shimizu K; Watanabe M; Kodama Y; Nomura S
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1998 Aug; 18(4):129-32. PubMed ID: 9866828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Opipramol (Insidon) in the treatment of somatoform disorders].
    Freyberger HJ; Grabe HJ; Maier W; Janca A; Stoll KD
    Fortschr Neurol Psychiatr; 1998 Dec; 66 Suppl 1():S25-30. PubMed ID: 9922924
    [No Abstract]   [Full Text] [Related]  

  • 6. [Update Opipramol].
    Gahr M; Hiemke C; Connemann BJ
    Fortschr Neurol Psychiatr; 2017 Mar; 85(3):139-145. PubMed ID: 28320023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversible hepatotoxicity of paroxetine in a patient with major depression.
    Helmchen C; Boerner RJ; Meyendorf R; Hegerl U
    Pharmacopsychiatry; 1996 Nov; 29(6):223-6. PubMed ID: 8956353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complex visual disturbances during maprotiline treatment.
    Yoshino T; Nisijima K; Shioda K; Kato S
    Psychiatry Clin Neurosci; 2012 Oct; 66(6):533-4. PubMed ID: 23066771
    [No Abstract]   [Full Text] [Related]  

  • 9. [A comparative clinical evaluation of the antidepressive activity of fluoxetine and fluvoxamine].
    Lopukhov IG
    Zh Nevrol Psikhiatr Im S S Korsakova; 1997; 97(4):53-7. PubMed ID: 9214192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One more case of hepatic injury due to amineptine.
    Lonardo A; Grisendi A; Mazzone E
    Ital J Gastroenterol Hepatol; 1997 Dec; 29(6):580-1. PubMed ID: 9513840
    [No Abstract]   [Full Text] [Related]  

  • 11. Serum levels of maprotiline and its adverse effects on depressed patients.
    Kurata K; Kido H; Hasegawa M; Inoue M; Yamaguchi N
    Jpn J Psychiatry Neurol; 1987 Jun; 41(2):247-54. PubMed ID: 3437612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatotoxicity associated with maprotiline therapy: case report.
    Moldawsky RJ
    J Clin Psychiatry; 1984 Apr; 45(4):178-9. PubMed ID: 6715293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac arrest caused by maprotiline in an elderly hemodialysis patient.
    Fukunishi I; Kitaoka T; Shirai T; Watanabe S
    Nephron; 1998; 78(2):225. PubMed ID: 9496744
    [No Abstract]   [Full Text] [Related]  

  • 14. A double-blind study comparing paroxetine and maprotiline in depressed outpatients.
    Szegedi A; Wetzel H; Angersbach D; Dunbar GC; Schwarze H; Philipp M; Benkert O
    Pharmacopsychiatry; 1997 May; 30(3):97-105. PubMed ID: 9211571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma free 3-methoxy-4-hydroxyphenylglycol predicts response to fluoxetine.
    Ko HC; Lu RB; Shiah IS; Hwang CC
    Biol Psychiatry; 1997 Apr; 41(7):774-81. PubMed ID: 9084896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Dopamine Receptor Antagonism of Opipramol: Relevance to Parkinsonism?
    Rozanski V; Laux G; Schwarz J
    Clin Neuropharmacol; 2019; 42(3):77-79. PubMed ID: 30829882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mania, a probable adverse drug reaction of opipramol in a patient with generalized anxiety disorder.
    Kar SK; Garg K
    Aust N Z J Psychiatry; 2015 Dec; 49(12):1225-6. PubMed ID: 25900970
    [No Abstract]   [Full Text] [Related]  

  • 18. Incidence of seizures with tricyclic and tetracyclic antidepressants.
    Jabbari B; Bryan GE; Marsh EE; Gunderson CH
    Arch Neurol; 1985 May; 42(5):480-1. PubMed ID: 3994566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Opipramol in behavioral pharmacologic anxiety and depression models].
    Gentsch C
    Fortschr Neurol Psychiatr; 1998 Dec; 66 Suppl 1():S17-20. PubMed ID: 9922922
    [No Abstract]   [Full Text] [Related]  

  • 20. Cross-over trial comparing the antidepressant effects of amineptine and maprotiline.
    Bornstein S
    Curr Med Res Opin; 1979; 6(2):107-10. PubMed ID: 380910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.